The history of Sildenafil presents a intricate picture for shareholders. While the initial release generated substantial gains, the expiration of its patent opened the avenue to generic alternatives, dramatically https://bookmarkssocial.com/story21565281/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet